Most Cited Papers In Last Two Years

Challenges and opportunities for treating intrahepatic cholangiocarcinoma: targeted therapy

MASLD co-aggregates with HCC in families-names change, fa(c)ts remain

Hepatic venous pressure gradient in hepatic resection for hepatocellular carcinoma

Targeted mutation-based therapy for intrahepatic cholangiocarcinoma

The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts

The role of exosomes in therapeutic resistance of hepatocellular carcinoma

Barriers to surveillance for hepatocellular cancer among patients with chronic liver disease -providers' perspectives

Treatment of intrahepatic cholangiocarcinoma: evidence for the role of percutaneous ablation

Trans-arterial chemoembolization and radioembolization for treatment of intrahepatic cholangiocarcinoma

Strategy for ERCP stenting in cholangiocarcinoma

Angiogenesis: the Yin and Yang in intrahepatic cholangiocarcinoma

Advanced and emerging radiation therapy approaches for intrahepatic cholangiocarcinoma

The role of gut microbiome and fecal microbiota transplantation in liver cancer and related complications: mechanisms and therapeutic potentials

The role of liver transplant for intrahepatic cholangiocarcinoma: the UK NHSBT liver advisory group pilot programme

Review of IDH mutations and potential therapies for intrahepatic cholangiocarcinoma

Insights on liver transplantation and multimodal treatment for intrahepatic cholangiocarcinoma

Perspective of tumor heterogeneity for treatments of intrahepatic cholangiocarcinoma with intrahepatic lithiasis

Liver transplantation for intrahepatic cholangiocarcinoma: a narrative review of the latest advances